UniProt ID | BRSK2_HUMAN | |
---|---|---|
UniProt AC | Q8IWQ3 | |
Protein Name | Serine/threonine-protein kinase BRSK2 | |
Gene Name | BRSK2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 736 | |
Subcellular Localization | Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Cytoplasm, perinuclear region. Endoplasmic reticulum. Detected at centrosomes during mitosis. Localizes to the endoplasmic reticulum in response to stress caused by tunicamycin. | |
Protein Description | Serine/threonine-protein kinase that plays a key role in polarization of neurons and axonogenesis, cell cycle progress and insulin secretion. Phosphorylates CDK16, CDC25C, MAPT/TAU, PAK1 and WEE1. Following phosphorylation and activation by STK11/LKB1, acts as a key regulator of polarization of cortical neurons, probably by mediating phosphorylation of microtubule-associated proteins such as MAPT/TAU at 'Thr-529' and 'Ser-579'. Also regulates neuron polarization by mediating phosphorylation of WEE1 at 'Ser-642' in postmitotic neurons, leading to down-regulate WEE1 activity in polarized neurons. Plays a role in the regulation of the mitotic cell cycle progress and the onset of mitosis. Plays a role in the regulation of insulin secretion in response to elevated glucose levels, probably via phosphorylation of CDK16 and PAK1. While BRSK2 phosphorylated at Thr-174 can inhibit insulin secretion. [PubMed: 22798068), BRSK2 phosphorylated at Thr-260 can promote insulin secretion] | |
Protein Sequence | MTSTGKDGGAQHAQYVGPYRLEKTLGKGQTGLVKLGVHCVTCQKVAIKIVNREKLSESVLMKVEREIAILKLIEHPHVLKLHDVYENKKYLYLVLEHVSGGELFDYLVKKGRLTPKEARKFFRQIISALDFCHSHSICHRDLKPENLLLDEKNNIRIADFGMASLQVGDSLLETSCGSPHYACPEVIRGEKYDGRKADVWSCGVILFALLVGALPFDDDNLRQLLEKVKRGVFHMPHFIPPDCQSLLRGMIEVDAARRLTLEHIQKHIWYIGGKNEPEPEQPIPRKVQIRSLPSLEDIDPDVLDSMHSLGCFRDRNKLLQDLLSEEENQEKMIYFLLLDRKERYPSQEDEDLPPRNEIDPPRKRVDSPMLNRHGKRRPERKSMEVLSVTDGGSPVPARRAIEMAQHGQRSRSISGASSGLSTSPLSSPRVTPHPSPRGSPLPTPKGTPVHTPKESPAGTPNPTPPSSPSVGGVPWRARLNSIKNSFLGSPRFHRRKLQVPTPEEMSNLTPESSPELAKKSWFGNFISLEKEEQIFVVIKDKPLSSIKADIVHAFLSIPSLSHSVISQTSFRAEYKATGGPAVFQKPVKFQVDITYTEGGEAQKENGIYSVTFTLLSGPSRRFKRVVETIQAQLLSTHDPPAAQHLSDTTNCMEMMTGRLSKCGSPLSNFFDVIKQLFSDEKNGQAAQAPSTPAKRSAHGPLGDSAAAGPGPGGDAEYPTGKDTAKMGPPTARREQP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
8 (in isoform 5) | Phosphorylation | - | 36.50 | 22210691 | |
15 | Phosphorylation | GGAQHAQYVGPYRLE CCCCCCEEECCEEEE | 14.25 | - | |
23 | Sumoylation | VGPYRLEKTLGKGQT ECCEEEEEECCCCCC | 54.35 | - | |
48 | Ubiquitination | TCQKVAIKIVNREKL ECCEEEEEECCHHHC | 30.75 | - | |
174 | Phosphorylation | VGDSLLETSCGSPHY CCCHHHHCCCCCCCC | 29.32 | 14976552 | |
178 | Phosphorylation | LLETSCGSPHYACPE HHHCCCCCCCCCCCH | 16.90 | - | |
245 | Phosphorylation | FIPPDCQSLLRGMIE CCCHHHHHHHCCCHH | 35.38 | 24719451 | |
260 | Phosphorylation | VDAARRLTLEHIQKH HHHHHHCCHHHHHHH | 28.43 | 16870137 | |
291 | Phosphorylation | PRKVQIRSLPSLEDI CCCEEEECCCCHHHC | 46.38 | 23607784 | |
294 | Phosphorylation | VQIRSLPSLEDIDPD EEEECCCCHHHCCHH | 50.08 | 29507054 | |
344 | Phosphorylation | LLDRKERYPSQEDED CCCCHHHCCCCCCCC | 14.34 | 29759185 | |
346 | Phosphorylation | DRKERYPSQEDEDLP CCHHHCCCCCCCCCC | 36.95 | 29759185 | |
367 | Phosphorylation | PPRKRVDSPMLNRHG CCCCCCCCHHHCCCC | 14.89 | 25159151 | |
382 | Phosphorylation | KRRPERKSMEVLSVT CCCCCCCCEEEEEEC | 26.79 | 25159151 | |
387 | Phosphorylation | RKSMEVLSVTDGGSP CCCEEEEEECCCCCC | 28.31 | 27732954 | |
389 | Phosphorylation | SMEVLSVTDGGSPVP CEEEEEECCCCCCCC | 26.08 | 29255136 | |
393 | Phosphorylation | LSVTDGGSPVPARRA EEECCCCCCCCHHHH | 28.40 | 29255136 | |
409 | Methylation | EMAQHGQRSRSISGA HHHHHCCCCCCCCCC | 38.33 | - | |
410 | Phosphorylation | MAQHGQRSRSISGAS HHHHCCCCCCCCCCC | 23.61 | - | |
411 | Methylation | AQHGQRSRSISGASS HHHCCCCCCCCCCCC | 39.95 | - | |
412 | Phosphorylation | QHGQRSRSISGASSG HHCCCCCCCCCCCCC | 23.50 | 29978859 | |
414 | Phosphorylation | GQRSRSISGASSGLS CCCCCCCCCCCCCCC | 29.56 | 29978859 | |
416 (in isoform 4) | Phosphorylation | - | 8.17 | 25849741 | |
417 | Phosphorylation | SRSISGASSGLSTSP CCCCCCCCCCCCCCC | 28.59 | 21406692 | |
418 | Phosphorylation | RSISGASSGLSTSPL CCCCCCCCCCCCCCC | 43.13 | 21406692 | |
421 | Phosphorylation | SGASSGLSTSPLSSP CCCCCCCCCCCCCCC | 30.29 | 29978859 | |
422 | Phosphorylation | GASSGLSTSPLSSPR CCCCCCCCCCCCCCC | 39.13 | 19958286 | |
423 | Phosphorylation | ASSGLSTSPLSSPRV CCCCCCCCCCCCCCC | 22.07 | 25159151 | |
426 | Phosphorylation | GLSTSPLSSPRVTPH CCCCCCCCCCCCCCC | 41.50 | 29978859 | |
427 | Phosphorylation | LSTSPLSSPRVTPHP CCCCCCCCCCCCCCC | 25.14 | 25159151 | |
431 | Phosphorylation | PLSSPRVTPHPSPRG CCCCCCCCCCCCCCC | 19.70 | 20363803 | |
435 | Phosphorylation | PRVTPHPSPRGSPLP CCCCCCCCCCCCCCC | 24.97 | 19369195 | |
437 | Methylation | VTPHPSPRGSPLPTP CCCCCCCCCCCCCCC | 63.66 | - | |
439 | Phosphorylation | PHPSPRGSPLPTPKG CCCCCCCCCCCCCCC | 25.25 | 20363803 | |
443 | Phosphorylation | PRGSPLPTPKGTPVH CCCCCCCCCCCCCCC | 45.36 | 20363803 | |
443 (in isoform 4) | Phosphorylation | - | 45.36 | 25159151 | |
444 (in isoform 4) | Phosphorylation | - | 31.01 | 25159151 | |
445 (in isoform 4) | Phosphorylation | - | 77.29 | 25159151 | |
447 | Phosphorylation | PLPTPKGTPVHTPKE CCCCCCCCCCCCCCC | 28.41 | 27732954 | |
451 | Phosphorylation | PKGTPVHTPKESPAG CCCCCCCCCCCCCCC | 35.97 | 28985074 | |
455 | Phosphorylation | PVHTPKESPAGTPNP CCCCCCCCCCCCCCC | 26.61 | 27732954 | |
459 | Phosphorylation | PKESPAGTPNPTPPS CCCCCCCCCCCCCCC | 23.23 | 27251275 | |
463 | Phosphorylation | PAGTPNPTPPSSPSV CCCCCCCCCCCCCCC | 55.24 | 28985074 | |
466 | Phosphorylation | TPNPTPPSSPSVGGV CCCCCCCCCCCCCCC | 56.96 | 27732954 | |
467 | Phosphorylation | PNPTPPSSPSVGGVP CCCCCCCCCCCCCCC | 27.28 | 27050516 | |
469 | Phosphorylation | PTPPSSPSVGGVPWR CCCCCCCCCCCCCHH | 35.03 | 27732954 | |
481 | Phosphorylation | PWRARLNSIKNSFLG CHHHHHHHHHHHCCC | 39.26 | 28464451 | |
485 | Phosphorylation | RLNSIKNSFLGSPRF HHHHHHHHCCCCCCH | 19.49 | 29396449 | |
489 | Phosphorylation | IKNSFLGSPRFHRRK HHHHCCCCCCHHCCC | 18.30 | 22167270 | |
501 | Phosphorylation | RRKLQVPTPEEMSNL CCCCCCCCHHHHHCC | 44.46 | 27732954 | |
506 | Phosphorylation | VPTPEEMSNLTPESS CCCHHHHHCCCCCCC | 31.78 | 20363803 | |
509 | Phosphorylation | PEEMSNLTPESSPEL HHHHHCCCCCCCHHH | 29.30 | 25159151 | |
512 | Phosphorylation | MSNLTPESSPELAKK HHCCCCCCCHHHHHH | 53.01 | 25159151 | |
513 | Phosphorylation | SNLTPESSPELAKKS HCCCCCCCHHHHHHH | 22.26 | 25159151 | |
520 | O-linked_Glycosylation | SPELAKKSWFGNFIS CHHHHHHHCCCCCCC | 27.25 | 30379171 | |
520 | Phosphorylation | SPELAKKSWFGNFIS CHHHHHHHCCCCCCC | 27.25 | 29507054 | |
544 | Phosphorylation | VIKDKPLSSIKADIV EECCCCHHHCCHHHH | 38.25 | 24719451 | |
608 | Phosphorylation | AQKENGIYSVTFTLL HEHHCCEEEEEEEEE | 9.85 | 28509920 | |
609 | Phosphorylation | QKENGIYSVTFTLLS EHHCCEEEEEEEEEC | 16.86 | 28509920 | |
611 | Phosphorylation | ENGIYSVTFTLLSGP HCCEEEEEEEEECCC | 12.64 | 28509920 | |
613 (in isoform 6) | Phosphorylation | - | 19.88 | 28985074 | |
613 | Phosphorylation | GIYSVTFTLLSGPSR CEEEEEEEEECCCCH | 19.88 | 28509920 | |
664 | Phosphorylation | GRLSKCGSPLSNFFD CCHHHCCCCHHHHHH | 31.94 | 27050516 | |
673 (in isoform 2) | Phosphorylation | - | 2.24 | 28985074 | |
690 | Phosphorylation | GQAAQAPSTPAKRSA CCCCCCCCCCCCCCC | 50.46 | 30631047 | |
695 (in isoform 4) | Phosphorylation | - | 40.98 | 28985074 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BRSK2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
WEE1_HUMAN | WEE1 | physical | 15150265 | |
MPIP2_HUMAN | CDC25B | physical | 15150265 | |
MPIP3_HUMAN | CDC25C | physical | 15150265 | |
TERA_HUMAN | VCP | physical | 23907667 | |
CSN5_HUMAN | COPS5 | physical | 22609399 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-382; SER-393; SER-412AND THR-509, AND MASS SPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-294; SER-367; SER-382;THR-389; SER-393; THR-422; SER-423; SER-427; SER-435 AND SER-466,PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-416 (ISOFORM 4), ANDMASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-382; SER-393 ANDSER-423, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-489, AND MASSSPECTROMETRY. | |
"Investigating the regulation of brain-specific kinases 1 and 2 byphosphorylation."; Bright N.J., Carling D., Thornton C.; J. Biol. Chem. 283:14946-14954(2008). Cited for: PHOSPHORYLATION AT THR-174, AND MUTAGENESIS OF THR-174 AND GLY-310. | |
"LKB1 is a master kinase that activates 13 kinases of the AMPKsubfamily, including MARK/PAR-1."; Lizcano J.M., Goeransson O., Toth R., Deak M., Morrice N.A.,Boudeau J., Hawley S.A., Udd L., Maekelae T.P., Hardie D.G.,Alessi D.R.; EMBO J. 23:833-843(2004). Cited for: FUNCTION, ENZYME REGULATION, PHOSPHORYLATION AT THR-174, ANDMUTAGENESIS OF THR-174. |